Ignite Creation Date:
2025-12-26 @ 11:12 AM
Ignite Modification Date:
2026-01-01 @ 12:44 AM
Study NCT ID:
NCT00337428
Status:
COMPLETED
Last Update Posted:
2016-11-16
First Post:
2006-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2007-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-14
First Submit QC Date:
None
Study First Post Date:
2006-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-01-14
Results First Submit QC Date:
None
Results First Post Date:
2010-02-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-27
Last Update Post Date:
2016-11-16
Last Update Post Date Type:
ESTIMATED